Celmatix

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Bayer/Evotec Collaboration O

In recent years, the women's health segment, which has long been overlooked in the venture capital community and on the innovation front, is attracting multi-billion-dollar attention. "Femtech" – whic

Ferring Pharmaceuticals AS has plumped for a scientist – Per Falk – to take over the reins when Michel Pettigrew steps down as president of the executive board at the end of the year and the Swede is

Nathalie Moll, currently secretary general of the European Association for Bioindustries,has been appointed EFPIA's director general – effective April, 2017. Eric Cornut will continue to lead EFPI